Safeguarding Women from Chemical Abortion Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Safeguarding Women from Chemical Abortion Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Trade.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H0B98B99B256A413594601610907FB992: 1. Short title This Act may be cited as the Safeguarding Women from Chemical Abortion Act.
- Section HD95B40E10F924B8A98FA8BBDC733B435: 2. Withdrawal of approval of the drug mifepristone for termination of pregnancy Effective upon the expiration of 14 days after the date of the enactment of...
- Section HBA49FE846AC747C8BBB8CF920815669D: 3. Federal tort for harm to women caused by chemical abortion drugs In this section: The term covered entity means a person that manufactures a covered...
- Section H6715E71ECD224139B377B0117FCE7EA0: 4. Rule of construction Nothing in this Act shall be construed to affect any provision of section 1461 of title 18, United States Code.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Safeguarding Women from Chemical Abortion Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Agriculture, Trade
Primary Purpose
This bill, Safeguarding Women from Chemical Abortion Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the Committee on Energy and Commerce, and in …
Introduced in House
Mrs. Harshbarger introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology